The premotor phase of Parkinson's disease

Parkinsonism & Related Disorders - Tập 13 - Trang S2-S7 - 2007
E. Tolosa1, Y. Compta1, C. Gaig1
1Neurology Service, c./ Villarroel 170, 08036 Barcelona, Catalonia, Spain

Tài liệu tham khảo

de Lau, 2006, Subjective complaints precede Parkinson disease: the Rotterdam study, Arch Neurol, 63, 362, 10.1001/archneur.63.3.noc50312 Abbott, 2003, Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu–Asia aging study, J Neurol, 250, 30 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Iranzo, 2006, Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study, Lancet Neurol, 5, 572, 10.1016/S1474-4422(06)70476-8 Gonera, 1997, Symptoms and duration of the premotor phase in Parkinson's disease, Mov Disord, 12, 871, 10.1002/mds.870120607 Becker, 2002, Early diagnosis of Parkinson's disease, J Neurol, 40 Hornykiewicz, 1987, Biochemical pathophysiology of Parkinson's disease, Adv Neurol, 45, 19 Riederer, 1976, Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis, J Neural Transm, 38, 277, 10.1007/BF01249445 Tissingh, 1998, Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]b-CIT SPECT, J Neurol, 245, 14, 10.1007/s004150050168 Tissingh, 1998, Iodine-123-N-vfluoropropyl-2b-carbomethoxy-3b-[4-iodophenyl]tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease, J Nucl Med, 39, 1143 Marek, 2001, [123I]B-CIT SPECT imaging assessment of the rate of Parkinson's disease progression, Neurology, 57, 2089, 10.1212/WNL.57.11.2089 Morrish, 1998, Measuring the rate of progression and estimating the premotoral period of Parkinson's disease with [18F]dopa PET, J Neurol Neurosurg Psychiatry, 64, 314, 10.1136/jnnp.64.3.314 Fearnley, 1991, Ageing and Parkinson's disease: SN regional selectivity, Brain, 114, 2283, 10.1093/brain/114.5.2283 Chaudhuri, 2006, Non-motor symptoms of Parkinson's disease: diagnosis and management, Lancet Neurol, 5, 235, 10.1016/S1474-4422(06)70373-8 Awerbuch, 1994, Autonomic functions in the early stages of Parkinson's disease, Int J Neurosci, 74, 9, 10.3109/00207459408987224 Abbott, 2001, Frequency of bowel movements and the future risk of Parkinson's disease, Neurology, 57, 456, 10.1212/WNL.57.3.456 Kaufmann, 2003, Autonomic failure in neurodegenerative disorders, Semin Neurol, 23, 351, 10.1055/s-2004-817719 Magerkurth, 2005, Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life, Clin Auton Res, 15, 76, 10.1007/s10286-005-0253-z Ashraf, 1997, Constipation in Parkinson's disease: objective assessment and response to psyllium, Mov Disord, 12, 946, 10.1002/mds.870120617 Camilleri, 1996, Gastrointestinal dysfunction in neurologic disease, Semin Neurol, 16, 203, 10.1055/s-2008-1040977 Visser, 2004, Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT, Mov Disord, 19, 1306, 10.1002/mds.20153 Ueki, 2004, Life style risks of Parkinson's disease: association between decreased water intake and constipation, J Neurol, 251, 18 Kaye, 2006, Excess burden of constipation in Parkinson's disease: a pilot study, Mov Disord, 21, 1270, 10.1002/mds.20942 Braak, 2006, Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology, Neurosci Lett, 396, 67, 10.1016/j.neulet.2005.11.012 Kupsky, 1987, Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells, Neurology, 37, 1253, 10.1212/WNL.37.7.1253 Rosenthal, 1987, Sigmoid volvulus in association with parkinsonism. Report of four cases, J Am Geriatr Soc, 35, 683, 10.1111/j.1532-5415.1987.tb04346.x Pfeiffer, 2003, Gastrointestinal dysfunction in Parkinson's disease, Lancet Neurol, 2, 107, 10.1016/S1474-4422(03)00307-7 Edwards, 1991, Gastrointestinal symptoms in Parkinson's disease, Mov Disord, 6, 151, 10.1002/mds.870060211 McCallum, 1998, Diabetic and nondiabetic gastroparesis, Curr Treat Options Gastroenterol, 1, 1, 10.1007/s11938-998-0001-2 Mathers, 1988, Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?, J Neurol Neurosurg Psychiatry, 51, 1503, 10.1136/jnnp.51.12.1503 Jackson, 1995, Lewy body dysphagia, J Neurol Neurosurg Psychiatry, 58, 756, 10.1136/jnnp.58.6.756-a Qualman, 1984, Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease, Gastroenterology, 87, 848, 10.1016/0016-5085(84)90079-9 Singer, 1989, Sexual dysfunction in men with Parkinson's disease, J Neurol Rehab, 3, 199 Welsh, 1997, Sexuality in women with Parkinson's disease, Mov Disord, 12, 923, 10.1002/mds.870120614 Wermuth, 1995, Sexual problems in young patients with Parkinson's disease, Acta Neurol Scand, 91, 453, 10.1111/j.1600-0404.1995.tb00445.x Bronner, 2004, Sexual dysfunction in Parkinson's disease, J Sex Marital Ther, 30, 95, 10.1080/00926230490258893 Goldstein, 2003, Dysautonomia in Parkinson's disease: neurocardiological abnormalities, Lancet Neurol, 2, 669, 10.1016/S1474-4422(03)00555-6 Kaufmann, 2004, Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies, Neurology, 63, 1093, 10.1212/01.WNL.0000138500.73671.DC Aranda, 1993, Vesical sphincter disorders in Parkinson disease, Rev Neurol, 149, 476 Wenning, 1999, Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed Parkinsonian syndromes: a clinicopathological study, J Neurol Neurosurg Psychiatry, 67, 620, 10.1136/jnnp.67.5.620 Compta, 2006, Pure autonomic failure with altered dopamine transporter imaging, Arch Neurol, 63, 604, 10.1001/archneur.63.4.604 Braune, 2001, The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of Parkinsonian syndromes, Clin Auton Res, 11, 351, 10.1007/BF02292766 Ansari, 1975, Olfactory function in patients with Parkinson's disease, J Chronic Dis, 28, 493, 10.1016/0021-9681(75)90058-2 Ward, 1983, Olfactory impairment in Parkinson's disease, Neurology, 33, 943, 10.1212/WNL.33.7.943 Quinn, 1987, Olfactory threshold in Parkinson's disease, J Neurol Neurosurg Psychiatry, 50, 88, 10.1136/jnnp.50.1.88 Doty, 1988, Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration, Neurology, 38, 1237, 10.1212/WNL.38.8.1237 Doty, 1992, Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry, 55, 138, 10.1136/jnnp.55.2.138 Tissingh, 2001, Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis., Mov Disord, 16, 41, 10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M Hawkes, 1997, Olfactory dysfunction in Parkinson's disease, J Neurol Neurosurg Psychiatry, 62, 436, 10.1136/jnnp.62.5.436 Stern, 1994, Olfactory function in Parkinson's disease subtypes, Neurology, 44, 266, 10.1212/WNL.44.2.266 Henderson, 2003, Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey, J Neurol Neurosurg Psychiatry, 74, 956, 10.1136/jnnp.74.7.956 Ross, 2005, Association of olfactory dysfunction with risk of future Parkinson's disease, Mov Disord, 20, 129 Ross, 2006, Association of olfactory dysfunction with incidental Lewy bodies, Mov Disord, 21, 2062, 10.1002/mds.21076 Sommer, 2004, Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT, Mov Disord, 19, 1196, 10.1002/mds.20141 Markopoulou, 1997, Olfactory dysfunction in familial Parkinsonism, Neurology, 49, 1262, 10.1212/WNL.49.5.1262 Montgomery, 1999, Abnormal performance on the PD test battery by asymptomatic first degree relatives, Neurology, 52, 757, 10.1212/WNL.52.4.757 Berendse, 2001, Subclinical dopaminergic dysfunction in a symptomatic Parkinson's disease patients’ relatives with a decreased sense of smell, Ann Neurol, 50, 34, 10.1002/ana.1049 Ponsen, 2004, Idiopathic hyposmia as a preclinical sign of Parkinson's disease, Ann Neurol, 56, 173, 10.1002/ana.20160 Marras, 2005, Smell identification ability in twin pairs discordant for Parkinson's disease, Mov Disord, 20, 687, 10.1002/mds.20389 Nausieda, 1992, Sleep in Parkinson's disease, 451 Lees, 1998, The nighttime problems of Parkinson's disease, Clin Neuropharmacol, 11, 512, 10.1097/00002826-198812000-00004 Factor, 1990, Sleep disorders and sleep effect in Parkinson's disease, Mov Disord, 5, 280, 10.1002/mds.870050404 Tandberg, 1998, A community-based study of sleep disorders in patients with Parkinson's disease, Mov Disord, 13, 895, 10.1002/mds.870130606 Stocchi, 2001, Sleep disorders in Parkinson's disease, Adv Neurol, 86, 289 Oerlemans, 2002, The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey, Sleep Med, 3, 147, 10.1016/S1389-9457(01)00127-7 Boeve, 2001, Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleopathy, Mov Disord, 16, 622, 10.1002/mds.1120 Schenk, 2002, REM sleep behaviour disorder: clinical, developmental and neuroscience perspectives 16 years after its formal identification in SLEEP, Sleep, 25, 120, 10.1093/sleep/25.2.120 Postuma, 2006, Potential early markers of Parkinson's disease in idiopathic REM sleep behavior disorder, Neurology, 66, 845, 10.1212/01.wnl.0000203648.80727.5b Stiasny-Kolster, 2005, Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alfa-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT, Brain, 128, 126, 10.1093/brain/awh322 Frucht, 1999, Falling sleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole, Neurology, 52, 1908, 10.1212/WNL.52.9.1908 Hobson, 2002, Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian movement disorder group, JAMA, 287, 455, 10.1001/jama.287.4.455 Abbott, 2005, Excessive daytime sleepiness and subsequent development of Parkinson disease, Neurology, 65, 1442, 10.1212/01.wnl.0000183056.89590.0d Santamaria, 1986, Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism, Neurology, 36, 1130, 10.1212/WNL.36.8.1130 Dooneief, 1992, An estimate of the incidence of depression in idiopathic Parkinson's disease, Arch Neurol, 49, 305, 10.1001/archneur.1992.00530270125028 Tandberg, 1996, The occurrence of depression in Parkinson's disease; a community based study, Arch Neurol, 53, 175, 10.1001/archneur.1996.00550020087019 Cummings, 1992, Depression and Parkinson's disease: a review, Am J Psychiatry, 149, 443, 10.1176/ajp.149.4.443 Slaughter, 2001, Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease, J Neuropsychiatry Clin Neurosci, 13, 187, 10.1176/appi.neuropsych.13.2.187 Burn, 2002, Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease, Mov Disord, 17, 445, 10.1002/mds.10114 Robins, 1976, Depression in patients with Parkinsonism, Br J Psychiatry, 128, 141, 10.1192/bjp.128.2.141 Lieberman, 2006, Depression in Parkinson's disease—a review, Acta Neurol Scand, 113, 1, 10.1111/j.1600-0404.2006.00536.x Montgomery, 2000, Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery, Mov Disord, 15, 467, 10.1002/1531-8257(200005)15:3<467::AID-MDS1007>3.0.CO;2-# Montgomery, 2000, Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery, Mov Disord, 15, 474, 10.1002/1531-8257(200005)15:3<474::AID-MDS1008>3.0.CO;2-X Nilsson, 2001, Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study, Acta Psychiatr Scand, 104, 380, 10.1034/j.1600-0447.2001.00372.x Nilsson, 2002, Major depressive disorder in Parkinson's disease: a register-based study, Acta Psychiatr Scand, 106, 202, 10.1034/j.1600-0447.2002.02229.x Schuurman, 2002, Increased risk of Parkinson's disease after depression: a retrospective cohort study, Neurology, 58, 1501, 10.1212/WNL.58.10.1501 Leentjens, 2003, Higher incidence of depression preceding the onset of Parkinson's disease: a register study, Mov Disord, 18, 414, 10.1002/mds.10387 Lauterbach, 2004, Differential DSM-III psychiatric disorder prevalence and profiles in dystonia and Parkinson's disease, J Neuropsychiatry Clin Neurosci, 16, 29, 10.1176/appi.neuropsych.16.1.29 Ishihara, 2006, A systematic review of depression and mental illness preceding Parkinson's disease, Acta Neurol Scand, 113, 211, 10.1111/j.1600-0404.2006.00579.x Mindham, 1970, Psychiatric symptoms in Parkinsonism, J Neurol Neurosurg Psychiatry, 33, 188, 10.1136/jnnp.33.2.188 Shiba, 2000, Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study, Mov Disord, 15, 669, 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5 Aarsland, 1999, Range of neuropsychiatric disturbances in patients with Parkinson's disease, J Neurol Neurosurg Psychiatry, 67, 492, 10.1136/jnnp.67.4.492 Marsh, 2000, Anxiety disorders in Parkinson's disease, Int Rev Psychiatry, 12, 307, 10.1080/09540260020002532 Weisskopf, 2003, Prospective study of phobic anxiety and risk of Parkinson's disease, Mov Disord, 18, 646, 10.1002/mds.10425 Cooper, 1991, Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability, Brain, 114, 2095, 10.1093/brain/114.5.2095 Pearce, 1995, The anterior olfactory nucleus in Parkinson's disease, Mov Disord, 10, 283, 10.1002/mds.870100309 Del Tredici, 2002, Where does Parkinson's disease pathology begin in the brain?, J Neuropathol Exp Neurol, 61, 413, 10.1093/jnen/61.5.413 Remy, 2005, Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system, Brain, 128, 1314, 10.1093/brain/awh445